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Abstract 
Colorectal cancer (CRC) is one of the most common malignant diseases and the forth common cause 
for death in the world. Circular RNAs (circRNAs) are a group of non-coding RNAs (ncRNAs), which 
have a covalent closed loop without 5’ and 3’ ends. Studies indicated that many circRNAs are 
differently expressed in CRC cells and tissues. Their different expression levels are significantly 
correlated with clinicopathological features and overall survival time of CRC patients. Additionally, 
they regulate CRC cell proliferation, apoptosis, invasion, and migration mainly by acting as competing 
endogenous RNAs (ceRNAs). In this review, we reviewed CRC-associated circRNAs, described their 
functions and mechanisms, discussed their potential as diagnostic or prognostic biomarkers and 
therapeutic targets of CRC. 
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1. Introduction 
Colorectal cancer (CRC), usually defined as adenocarcinoma in colon or rectum, is one of the most 
common malignant diseases and the forth common cause for death in the world as well (Kolligs, 2016). 
The occurrence and development of CRC are affected by both genetic and environmental factors 
(Kolligs, 2016). CRC is often considered as a “lifestyle” disease. Besides, deregulation of oncogenes 
(K-ras and N-ras), suppressor genes (APC, DCC, TP53, SMAD2, SMAD4) and genes related to DNA 
repair (MMR and MUTYH) may contribute to the carcinogenesis of CRC (Taborda, Ramirez, & Bernal, 
2017). 
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Recently, high-throughput technology has showed that lots of our genome are transcribed; but many of 
them cannot be translated to proteins but have functions and are named as non-coding RNAs (ncRNAs) 
(Lizarbe et al., 2017). NcRNAs can regulate several biological processes like proliferation, 
differentiation, apoptosis and inflammation. Deregulation of ncRNAs would promote or repress the 
occurrence and development of tumors including CRC (Lizarbe et al., 2017). There are several ways 
for the classification of ncRNAs. Based on shape, they can be divided into two groups: linear ncRNAs 
and circular RNAs (circRNAs). According to their length, linear RNAs can be further divided into two 
classes: 1) small ncRNAs (sncRNAs), which length is shorter than 200nt. The most attractive type of 
sncRNAs is microRNAs (miRNAs); 2) long ncRNAs (lncRNAs), which length is up to 200nt. 
Nowadays, growing studies reveal that miRNAs and lncRNAs are involved in the development, 
progression, and prognosis of CRC (Shaker et al., 2018; Wang et al., 2015). 
CircRNAs have a covalent closed loop without 5’ and 3’ ends (Tian et al., 2018; Li et al., 2018). 
According to their component, circRNAs can be divided into three types: exonic circRNAs, intronic 
circRNAs, and exon-intron circRNAs (Fu et al., 2018). There are three ways of circularization (Figure 
1): Spliceosome-dependent circulation, cis-elements driven circularization and protein factors 
regulation circulation (Liu et al., 2017; Chen, 2016). It has been demonstrated that circRNAs are more 
stable than linear RNAs, have tissue-specificity, regulate gene expression, and exist in exosomes that 
can be secreted into body fluids (Salzman et al., 2013; Dou et al., 2016). These features have been 
renewed interest in cancer research including CRC research. 
 
 
Figure 1. CircRNAs are Produced from pre-mRNA by Back-splicing 
There are three ways of circularization:  
a. Spliceosome-dependent circulation: Two sites of pre-mRNA (one 5′ donor site and one 3′ acceptor 
site) with spliceosomal small nuclear ribonucleoproteins (snRNPs) joined together to form a circRNA 
following the spliceosomal machinery. 
b. Cis-elements driven circularization: Cis-elements contain reverse complementary sequences (RCM）
and repetitive elements like Alu which enriched in introns and promote circularization of exons. 
c. Protein factors regulation circulation: RNA-binding protein (RBP) including the splicing factor 
Muscleblind (Mbl) and quaking (QKI) can bind with introns of pre-mRNA and upregulate circRNAs. 
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Growing studies showed that circRNAs have several functions in biological processes, like regulating 
gene transcription (Zhang et al., 2013), taking part in selective splicing (Ashwal-Fluss et al., 2014), 
inhibiting the maturation of RNA (Holdt et al., 2016), participating in translation process (Das, Gorospe, 
& Panda, 2018), promoting protein-protein interactions (Hinds et al., 1992), and affecting protein 
localization (Du et al., 2017). But in cancer researches, the relatively more studied topic is that 
circRNAs act as competing endogenous RNAs (ceRNAs) to affect cancer associated gene expression 
(Greene et al., 2017; Hsiao et al., 2017; Li et al., 2017). 
For CRC, a growing number of circRNAs have been identified deregulated expression in CRC tissues 
and cell lines. Some circRNAs are involved in CRC progression by regulating cell proliferation, 
apoptosis, migration, invasion and so on (Table 1). Other circRNAs may be potential diagnostic or 
prognostic biomarkers of CRC (Table 2). 
 
Table 1. Deregulated CircRNAs in Colorectal Cancer (CRC) and Their Functions 
No. CircRNA  Alias Dereg
ulation 
Gene 
symbol 
Genome 
position 
Function Gene affected* Ref. 
1 hsa_circ_0026
782 
circITGA
7 
↓ ITGA7 chr12: 
56094682- 
56094938 
proliferation (-); 
metastasis (-); 
invasion (-) 
˧ miR-370-3p → 
NF1, ˧ RREB1 → 
ITGA7 (Ras 
pathway) 
Li et 
al. 
(2018) 
2 hsa_circ_0026
344 
__ ↓ ACVR
L1 
chr12: 
52314542- 
52317145 
proliferation (-)；
invasion (-)；
apoptosis (+) 
˧ miR-21 
andmiR-31 
Yuan 
et al. 
(2018) 
3 hsa_circ_0000
567 
hsa_circ_
001983 
↓ SETD3 chr14: 
99924615- 
99932150 
proliferation (-); 
migration (-) 
_ Wang 
and Li 
(2018) 
4 hsa_circ_0014
717  
__ ↓ CCT3 chr1: 
156290629-
156304709 
proliferation (-); 
colony formation 
(-); arrest G0/G1 
phase (+) 
→ P16 Wang 
et al. 
(2018) 
5 ciRS-7 CDR1as; 
hsa_circ_
0001946 
↑ CDR1 chrX: 
139865339-
139866824 
proliferation (+); 
migration (+); 
invasion (+); 
apoptosis (-) 
˧ miR-7, 
→EGFR/ RAF1 
(EGFR/RAF1/M
APK pathway) 
Weng 
et al. 
(2017) 
6 hsa_circ_0001
724 
hsa_circ_
000984 
↑ CDK6 chr7: 
92462409- 
92463134 
proliferation (+); 
migration (+); 
invasion (+); 
tumor formation 
(+) 
˧ miR-106b, 
→CDK6 
Xu et 
al. 
(2017) 
7 hsa_circ_0000
069 
hsa_circ_
001061 
↑ STIL chr1: 
47745912- 
47748131 
proliferation (+); 
migration (+); 
invasion (+)  
__ Guo et 
al. 
(2016) 
8 __ circ-BAN
P; 
↑ BANP __ proliferation (+) — Zhu et 
al. 
(2017) 
9 __ circCCDC ↑ CCDC6 __ proliferation (+); ˧ miRNA-33b and Hsiao 
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66 6 migration (+); 
metastasis (+); 
miR-93, → MYC et al. 
(2017) 
10 __ circRNA_
100290 
↑ SLC30
A7 
chr1: 
101372407–
101379362 
proliferation (+); 
migration (+); 
invasion (+); 
apoptosis (-) 
˧ miR-516b, 
→FZD4 
→Wnt/b-catenin 
pathway 
Fang 
et al. 
(2018) 
11 hsa_circ_0020
397 
__ ↑ DOCK1 chr10: 
128768965-
128926028 
proliferation (+); 
viability (+); 
invasion (+); 
apoptosis (-) 
˧ miR-138, → 
PD-L1 and TERT 
Zhang, 
Xu and 
Wang 
(2017) 
12 hsa_circ_0000
284 
circHIPK
3; 
hsa_circ_
000016 
↑ HIPK3 chr11: 
33307958- 
33309057 
proliferation (+); 
migration (+); 
invasion (+); 
apoptosis (-) 
cMyb→circHIPK
3, ˧ miR-7, 
→proto-oncogene
s (FAK, IGF1R, 
EGFR, YY1) 
Zeng 
et al. 
(2018) 
13 hsa_circ_0007
534 
__ ↑ DDX42 chr17: 
61869771- 
61877977 
proliferation (+); 
apoptosis (-) 
__ Zhang 
et al. 
(2018) 
*: ┤, inhibit; →, promote. 
 
Table 2. CircRNAs as CRC Diagnostic/Prognostic Biomarkers 
No. CircRNA  Deregu
lation 
Biomarker Patients 
(n) 
Detection 
method 
Prognostic/diagn
osis value 
Refs. 
1 hsa_circ_0026782; 
circITGA7 
↓ diagnostic 177 qRT-PCR; AUC 0.879; 
sensitivity 0.928; 
specificity 0.667 
Li et al. 
(2018) 
2 hsa_circ_0026344 
 
↓ 
prognostic  32 
qRT-PCR; 
ISH 
__ Yuan et 
al. (2018) 
3 circRNA0003906 ↓ diagnostic  122 qRT-PCR AUC 0.818; 
sensitivity 0.803; 
specificity 0.725 
Zhuo et 
al. (2017) 
4 Hsa_circ_0001649; 
hsa_circ_001599 
↓ diagnostic  64 qRT-PCR AUC 0.857; 
sensitivity 0.828; 
specificity 0.781 
Ji et al. 
(2018) 
5 hsa_circ_0000567 ↓ diagnostic  102 qRT-PCR AUC 0.865; 
sensitivity 0.828; 
specificity 0.781 
Wang 
and Li 
(2018) 
6 hsa_circ_0014717  ↓ diagnostic 
prognostic 
46 qRT-PCR AUC 0.683 Wang et 
al. (2018) 
7 hsa_circ_0001451; 
hsa_circ_001988 
↓ diagnostic  31 qRT-PCR AUC 0.788; 
sensitivity 0.68; 
Wang et 
al. (2015) 
www.scholink.org/ojs/index.php/rhs                   Research in Health Science                         Vol. 4, No. 2, 2019 
130 
Published by SCHOLINK INC. 
specificity 0.73 
8 circCCDC66 ↑ diagnostic; 
prognostic  
229 qRT-PCR AUC 0.884  Hsiao et 
al. (2017) 
9 ciRS-7；CDR1as; 
hsa_circ_0001946 
↑ prognostic 362 qRT-PCR __ Weng et 
al. (2017) 
10 circRNA_100290 ↑ prognostic 44 qRT-PCR
； 
ISH 
__ Fang et 
al. (2018) 
11 hsa_circ_0000284; 
circHIPK3; 
hsa_circ_000016 
↑ 
prognostic 178 qRT-PCR 
__ Zeng et 
al. (2018) 
qRT-PCR, quantitative reverse transcription-polymerase chain reaction; AUC, area under ROC curve; 
ISH, In situ hybridization; 
 
2. Down Regulated CircRNAs in CRC 
CircITGA7 
The integrin subunit alpha 7 (ITGA7) pre-mRNA can produce two types of RNA: ITGA7 mRNA and 
circITGA7. CircITGA7, also known as hsa_circ_0026782, is produced from exon 4 of ITGA7 
pre-mRNA via back-splicing (Li et al., 2018). ITGA7 is one of the extracellular matrix binding proteins. 
Its gene has been reported to be a tumor-suppressor gene in prostate cancer, leiomyosarcoma and 
malignant pleural mesothelioma (Li et al., 2018; Tan et al., 2013; Laszlo et al., 2015). Recently, 
circITGA7 and ITGA7 were both found to down-regulated in CRC cell lines and tissues (Li et al., 
2018). In the meanwhile, lower circITGA7 expression was significantly associated with tumor size, 
lymph node metastasis, metastasis and TNM stage (Li et al., 2018). Overexpression of circITGA7 can 
restrain CRC cell proliferation, migration and arrest cells in G0/G1 phase (Li et al., 2018). In sharp 
contrast, the knockdown of circITGA7 has opposite results. Further study showed that circITGA7 
could modulate Ras signaling pathway. Mechanism study showed that circITGA7 bound with 
miR-370-3p and then increased expression of neurofibromin 1 (NF1), one Ras pathway inhibitor, 
resulting in suppressing Ras signaling pathway (Li et al., 2018). Besides, circITGA7 can upregulate 
ITGA7 expression by inhibiting Ras responsive element binding protein 1 (RREB1) in CRC (Li et al., 
2018). These data indicated that circITGA7 might be a new target for CRC treatment. 
Circ_0026344 
Nowadays, miR-31 and miR-21 are reported to be oncogenic miRNAs in multiple cancers including in 
CRC (Saraggi et al., 2018; Zadeh, Ranji, & Motamed, 2015; Pennelli et al., 2015; Cui, Zhang, Ye, 
Zheng, Song, Deng, … Guo, 2013; Zhang, Guo, Li, Xiao, Miao, Jiang, & Zhuo, 2010; Guo, Miao, Xiao, 
Huan, Jiang, Meng, & Wang, 2009; Zheng et al., 2015; Ning et al., 2014; Gao et al., 2014; Zheng, Cui, 
Sun, Zhou, Yuan, Huo, … Guo, 2011-2012; Wu et al., 2017). Circ_0026344, a significantly 
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down-regulated circRNA in CRC tissues, was correlated with advanced stages, metastasis and poor 
prognosis in CRC patients (Yuan et al., 2018). Circ_0026344 was further found acting as a miRNA 
sponge of miR-31 and miR-21 in CRC (Yuan et al., 2018). Afterwards, overexpression of circ_0026344 
significantly suppressed CRC cell proliferation, enhanced apoptosis while significantly decreased 
invasion in vitro and inhibited CRC growth in vivo (Yuan et al., 2018). Interestingly, overexpression of 
either miR-21 or miR-31 could only reverse part effects of up-regulated circ_0026344 on proliferation, 
invasion and apoptosis, but both miR-31 and miR-21 ectopic expression at the same time reversed all 
the effects on CRC cells (Yuan et al., 2018). These results indicate that circ_0026344 function by 
binding both miR-31 and miR-21 in CRC cells. In a word, circ_0026344 may play a tumor-suppressive 
role in CRC through sponge both miR-31 and miR-21. 
CircRNA0003906 
CircRNA0003906 is a 14317 nt circRNA. Its gene is located at chr6:29989443–30003760. Zhuo et al. 
reported that circRNA0003906 was significantly downregulated in several CRC cell lines and CRC 
tissues (Zhuo et al., 2017). Low expression of circRNA0003906 was associated with poor 
differentiation and lymphatic node metastasis. The area under ROC curve (AUC) was 0.818, with the 
specificity and sensitivity of 0.725 and 0.803, respectively (Zhuo et al., 2017). These indicate that 
circRNA0003906 may be a biomarker in the diagnosis of CRC. 
Hsa_circ_0001649 
The circRNA hsa_circ_0001649 is generated from Snf2 histone linker phd ring helicase (SHPRH) gene. 
It has been reported that hsa_circ_0001649 is a potential novel prognosis biomarker and therapeutic 
target in hepatocellular carcinoma (HCC), pancreatic ductal adenocarcinoma, cholangiocarcinoma and 
glioma (Xu et al., 2018; Wang et al., 2018; Qin et al., 2016; Jiang et al., 2018). For CRC, qRT-PCR 
results showed that hsa_circ_0001649 expression was significantly down in CRC tissues and cell lines 
(Ji et al., 2018). What’s more, Ji at el. detected the expression of hsa_circ_0001649 in serum from 
before and after surgery CRC patients, and found that hsa_circ_0001649 levels after surgery were 
increased (Ji et al., 2018). Besides, the AUC was 0.857 with specificity 0.781 and sensitivity 0.828 (Ji 
et al., 2018). These results showed that hsa_circ_0001649 could be a new biomarker for CRC. 
Hsa_circ_0000567 
Hsa_circ_0000567, a circRNA with 683 nt, is generated from exon 2-6 of SET domain-containing 3 
(SETD3) pre-mRNA. Firstly, RNase R and actinomycin D treatments proved that hsa_circ_0000567 
was more stable than linear mRNA (Wang & Li, 2018). Then, hsa_circ_0000567 was verified to 
down-regulate in CRC tissues, and was negatively correlated with tumor size, distant metastasis, lymph 
node metastasis and TNM stage (Wang & Li, 2018). The consistent results from in vitro experiments 
demonstrated that hsa_circ_0000567 played a suppressor role in CRC (Wang & Li, 2018). Furthermore, 
loss-of-function assay showed that hsa_circ_0000567 suppressed proliferation and migration of CRC 
cells (Wang & Li, 2018). The AUC was 0.865, with specificity 0.764, sensitivity 0.833, and Youden’s 
index 0.598 (Wang & Li, 2018). Since that some circRNAs stably exist in plasma or exosomes (Li et al., 
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(2015), Wang et al. observed whether hsa_circ_0000567 in blood exosome from CRC patients can be 
detected. They found that hsa_circ_0000567 levels in blood exosome from CRC patients were lower 
than those from normal subjects (Wang & Li, 2018). These findings indicated that circulating 
hsa_circ_0000567 may be used more conveniently for CRC screening. 
Hsa_circ_0014717 
Hsa_circ_0014717 of 516 nt in length is transcripted from chr1:156290629-156304709. Its lower 
expression was closely associated with distant metastasis, TNM stage and poor prognosis (Wang et al., 
2018). CCK-8 assay, colony formation assay and flow cytometry were demonstrated that 
overexpression of hsa_circ_0014717 could weaken cell viability and colony formation number as well 
as arrest cell at G0/G1 phase (Wang et al., 2018). The phenomenon of slower tumor growth and lower 
tumor weight in nude mice indicated that hsa_circ_0014717 might be a tumor suppressor in CRC 
(Wang et al., 2018). Further study showed that hsa_circ_0014717 could enhance the expression of P16 
(Wang et al., 2018). Previous studies showed that P16 is one of cyclin-dependent protein kinase 
inhibitors (Witkiewicz et al., 2011; Rayess, Wang, & Srivatsan, 2012). The rescue assay was performed 
to reveal that knockdown of P16 could reverse the inhibition function of hsa_circ_0014717 in CRC 
cells (Wang et al., 2018). These data suggested that hsa_circ_0014717 may be a prognosis marker for 
CRC diagnosis and a promising target for CRC therapy. 
 
3. Up Regulated CircRNAs in CRC 
Circular RNA CCDC66 
CircRNACCDC66 (circRNACCDC_66_10_8) was found upregulated in CRC cell lines, the 
pre-cancerous polyp tissues and CRC tissues (Hsiao et al., 2017). The high expression of 
circRNACCDC66, but not linear transcript of CCDC66, was correlated with poor prognosis of CRC 
(Hsiao et al., 2017). The AUC of circRNACCDC66 was 0.8843, indicating that circRNACCDC66 is a 
good biomarker for CRC prognosis and diagnosis (Hsiao et al., 2017). Further study demonstrated that 
knockdown of circRNACCDC66 by siRNA successfully reduced CRC cell proliferation, migration and 
invasion (Hsiao et al., 2017). Besides, knockdown circRNACCDC66 inhibited tumor growth and 
cancer invasion in xenograft and orthotopic mouse models, respectively. Gene set enrichment analysis 
(GSEA) showed that predicted circRNACCDC66-regulated genes were enriched in tumor 
transcriptome (Hsiao et al., 2017). The levels of the targeted genes such as enhancer of zeste 2 
polycomb repressive complex 2 subunit (EZH2), DNA methyltransferase 3 beta (DNMT3B), Yes 
associated protein 1 (YAP1) and MYC proto-oncogene (Myc), were significantly downregulated by 
circCCDC66 knockdown or upregulated by overexpression of circCCDC66 (Hsiao et al., 2017). In 
addition, luciferase assays further demonstrated that circRNACCDC66 may protect oncogenic target 
genes by sponging a number of miRNAs in CRC (Hsiao et al., 2017). These findings indicated that 
circRNACCDC66 may be a useful biomarker for CRC diagnosis and prognosis and may emphasize a 
novel oncogene function of circRNAs in CRC. 
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CiRS-7 
CiRS-7 (also named as cerebellar degeneration-related protein 1 antisense RNA, hsa_circ_0001946 or 
Cdr1as) is a super star in the circRNA field. It is a ceRNA by acting as a miRNA sponge with 73 
binding sites of miR-7 to efficiently influence miR-7 activities in many human diseases (Weng et al., 
2017; Hansen et al., 2013; Zhang et al., 2017). To date, ciRS-7 has been declared to express extensively 
in astrocytoma, neuroblastomas, gastric cancer, esophageal squamous cell carcinoma, liver cancer, and 
lung carcinomas (Weng et al., 2017; Su et al., 2018; Sang et al., 2018; Pan, 2018; Xu et al., 2017; Li et 
al., 2017). Thus, it is an important regulator in cancers. Recently, Weng et al. discovered that 
upregulated ciRS-7 in CRC tissues was significantly correlated with some clinicopathological features 
such as tumor size, lymph node metastasis, distant metastasis, and TNM stages (Weng et al., 2017). 
Besides, the higher expression of ciRS-7 was associated with poor overall survival. In vitro 
experiments showed that ciRS-7 overexpression notably reduced miR-7 function in CRC cells, which 
was consist with in vivo experiments (Weng et al., 2017). Further study found that ciRS-7 weakened the 
inhibitory effect of miR-7 on Raf-1 proto-oncogene (RAF1) and epidermal growth factor receptor 
(EGFR) (Weng et al., 2017). In addition, the related expression between ciRS-7, miR-7 and 
EGFR/RAF1 in CRC tissues indicated that ciRS-7 may play a crucial role in EGFR/RAF1 pathways 
via sponging miR-7 (Weng et al., 2017). These results showed that ciRS-7 may be served as a 
therapeutic target in CRC. 
Hsa_circ_000984 
Hsa_circ_000984 is a circRNA transcripted from chromosomal region 7q (92462409-92463134), 
encoded by the cyclin-dependent kinase 6 (CDK6) gene. CDK6, involving in progression of cell cycle, 
takes part in the development and prognosis of multiple cancers (Tadesse et al., 2015). Xu et al. found 
that hsa_circ_000984 was highly expressed in CRC tissues and cell lines, correlated with advanced 
TNM stage in clinicopathological features analysis (Xu et al., 2017). CCK-8 assay and colony 
formation assay showed that knockdown of hsa_circ_000984 could obviously reduce cell growth rate 
and the numbers of colony formation mainly due to the disorder of cell cycle (Xu et al., 2017). 
Meanwhile, knockdown of hsa_circ_000984 could abate the invasion and migration both in CRC cell 
lines and CRC xenograft model (Xu et al., 2017). As for molecular mechanisms, further studies 
demonstrated that hsa_circ_000984 can be served as a miRNA sponge of miR-106b to regulate 
downstream target gene CDK6 (Xu et al., 2017). These suggested that hsa_circ_000984 may play a 
significant role in CRC progression and therapeutic strategy. 
Hsa_circ_0000069 
Hsa_circ_0000069 is an up-regulated circRNA selected from a circRNA microarray and later validated 
in both CRC cell lines and tissues (Guo et al., 2016). The expression of hsa_circ_0000069 was related 
to CRC patients’ TNM stages (Guo et al., 2016). In CRC cells, knockdown of hsa_circ_0000069 
distinctly inhibited cell proliferation, invasion and migration (Guo et al., 2016). Furthermore, flow 
cytometry analysis revealed that knockdown of hsa_circ_0000069 arrested cells at G0/G1 phase (Guo 
www.scholink.org/ojs/index.php/rhs                   Research in Health Science                         Vol. 4, No. 2, 2019 
134 
Published by SCHOLINK INC. 
et al., 2016). These suggested that hsa_circ_0000069 may be involved in CRC progression, and may be 
a therapeutic target for CRC treatment. 
Circ-BANP 
Circ-BANP, a circular RNA screened by a circRNA microarray of CRC with remarkably upregulated 
expression, later was validated by both RT-PCR and fluorescence in situ hybridization in CRC tissues 
and cell lines (Zhu et al., 2017). It was also reported to promote lung cancer growth, migration and 
invasion via miR-503/LARP1 signaling recently (Han et al., 2018). However, there is no correlation 
between circ-BANP expression and clinicopathologic features of patients with CRC (Zhu et al., 2017). 
Simultaneously, Zhu et al. used siRNA to explore the biological function of circ-BANP and found that 
knockdown of circ-BANP could suppress the CRC cell proliferation, colony formation and expression 
of p-Akt (Zhu et al., 2017). These suggested that circ-BANP could implicate in the proliferation of 
CRC cells by PI3K/Akt pathway. 
CircRNA_100290 
Another up-regulated circRNA in CRC tissues and cell lines is circRNA_100290 that was also 
validated by qRT-PCR and ISH (Fang et al., 2018). Further analysis showed that higher level of 
circRNA_100290 expression was correlated with metastasis leading to poor prognosis in CRC (Fang et 
al., 2018). Knockdown circRNA_100290 could inhibit proliferation, migration and invasion but 
increase the cellular apoptosis of CRC cells (Fang et al., 2018). Furthermore, through bioinformatics 
analysis, qRT-PCR, luciferase reporter assay, circRNA_100290 was found direct interact with 
miR-516b to target frizzled class receptor 4 (FZD4) and then active cyclin D1 (CCND1), cyclin D1 
(CCND2), MYC, SRY-box 4 (SOX4) and transcription factor 7 (TCF7) (target genes of Wnt/b-catenin 
pathway) (Fang et al., 2018). Then, rescue assays verified the role of 
circRNA_100290/miR-516b/FZD4/Wnt/b-catenin pathway in CRC (Fang et al., 2018). These data 
revealed that circRNA_10029 may be a potential biomarker and a hopeful treatment target for CRC. 
Has_circ_0020397 
Hsa_circ_0020397, generated from dedicator of cytokinesis 1 (DOCK1), was observed upregulated in 
CRC cell lines (Zhang, Xu, & Wang, 2017). It was predicted to have several binding sites with 
miR-138 by using common bioinformatic algorithms (miRanda and RNAhybrid 2.2) (Zhang, Xu, & 
Wang, 2017). After that, qRT-PCR analysis and dual-luciferase reporter assay got the consistent 
conclusion as the prediction (Zhang, Xu, & Wang, 2017). Further study showed that hsa_circ_0020397 
could repress the function of miR-138, leading to increasing the expression of miR-138 target gene 
telomerase reverse transcriptase (TERT) and programmed death-ligand 1 (PD-L1) (Zhang, Xu, & Wang, 
2017). Previous studies showed that TERT activated telomerase, which maintain telomere length, offer 
cancer cells unlimited replication capacity (Liu, Yuan, & Xu, 2016). Besides, overexpression of 
hsa_circ_0020397 could promote CRC cells viability, invasion but inhibit apoptosis by increasing the 
expression of miR-138 target genes (TERT and PD-L1) (Zhang, Xu, & Wang, 2017). These suggested 
that hsa_circ_0020397 may serve as an oncogene in CRC initiation and progression. 
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CircHIPK3 
CircHIPK3 (hsa_circ_0000284), generated from the homeodomain interacting protein kinase 3 (HIPK3) 
gene Exon2, plays as oncogene or anti-tumor roles in various cancers. CircHIPK3 may be an oncogene 
in glioma tissues, nasopharyngeal carcinoma, epithelial ovarian cancer, hepatocellular carcinoma, and 
gastric cancer (Jin et al., 2018; Liu et al., 2018; Ke et al., 2018; Cheng et al., 2018; Chen et al., 2018) . 
However, circHIPK3 was down-regulated in osteosarcoma (OS) tissues, and overexpression of 
circHIPK3 could restrain OS cell proliferation, invasion and migration (Xiao-Long, Kun-Peng, & 
Chun-Lin, 2018). Besides, Li et al. showed that circHIPK3 may sponge miR-558 to suppress the 
expression of heparanase (HPSE) resulted in inhibiting bladder cancer growth and metastasis (Li et al., 
2017).  
CircHIPK3 was found to up-regulate in CRC tissues and cell lines (Zeng et al., 2018). Its expression 
levels were significantly correlated with tumor size, lymph metastasis, distant metastasis, and TNM 
stage (Zeng et al., 2018). Cox multivariate survival analysis showed that high circHIPK3 expression 
was an independent prognostic factor for CRC patients (Zeng et al., 2018). Further in vivo study 
showed that circHIPK3 knockdown significantly inhibited the number of colony, cell proliferation but 
promoted the number of apoptotic cells to retard the CRC progression (Zeng et al., 2018). CircNet 
database, qRT-PCR, luciferase reporter assays combined with FISH demonstrated that circHIPK3 may 
sponge miR-7 in CRC (Zeng et al., 2018). More recently, miR-7, a well-known tumor suppressor, was 
reported to interact with ciRS-7 which has 73 binding sites to regulate CRC progression (Weng et al., 
2017). CircHIPK3 overexpression significantly reversed suppression of aggressive phenotypes induced 
by miR-7 in CRC cells and promotion the expression of miR-7 target oncogene (YY1 transcription 
factor (YY1), EGFR, protein tyrosine kinase 2 (FAK) and insulin like growth factor 1 receptor (IGF1R)) 
via acting as a miRNA sponge (Zeng et al., 2018). Moreover, xenograft mouse models and metastasis 
models demonstrated that silencing of circHIPK3 with overexpression of miR-7 may play an additive 
inhibitory effect on growth and metastasis in CRC (Zeng et al., 2018). These results suggested that 
circHIPK3/miR-7 axis may be a treatment target for CRC.  
 
4. Conclusion and Future Perspectives 
Growing reports showed that some circRNAs are differently expressed in CRC cells and tissues (Figure 
2). Their different expression levels are significantly correlated with clinicopathological features and 
overall survival time of CRC patients. Some of them can take part in CRC progression through 
regulating CRC cell proliferation, migration, invasion, and apoptosis mainly by acting as miRNA 
sponge. Because circRNAs are more stable, abundant, tissue-specific, exist in exosomes, they are 
potential diagnostic or prognostic biomarkers and therapeutic targets for CRC. 
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Figure 2. Deregulated CircRNAs in Colorectal Cancer (CRC). Some CircRNAs are Differently 
Expressed in CRC 
(Blank, down-regulated; red, up-regulated.) 
 
Compared with proteins, mRNAs, miRNAs and lncRNAs, there are a lot of unknown space of 
CRC-related circRNAs that we should study. So far, among these reported CRC-associated circRNAs, 
only a few functional circRNAs have been explored. Scientists studied circRNAs mainly through RNA 
sequencing or microarray, focused on validating the function of miRNAs sponge. Many questions 
about CRC-associated circRNAs’ biogenesis, degradation, function, and molecular mechanisms are 
waiting to be answered. 
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